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Summary
Introduction: While the incidence of pulmonary and extrapulmonary tuberculosis is growing in
patients of advanced age, immunocompromised subjects, and immigrants coming in from
developing countries [Keller A, Delavelle J, Howarth N, Bianchi S, Garcia J. Spinal and neuro-
tuberculosis in an Asian immigrant. JBR-BTR 2002;85:136—7; Sabbatani S, Manfredi R, Legnani G.
Chiodo F. Tuberculosis in a metropolitan area of northern Italy: epidemiological trends and public
health concerns. Eur J Epidemiol 2004;19:501—3], the concomitant occurrence of cerebral
cryptococcosis plus brain and respiratory tuberculosis in a young and otherwise healthy patient,
without an evident cause of immunodeficiency and without an obvious exposure, is exceedingly
rare [Silber E, Sonnenberg P, Koornhof HJ, Morris L, Saffer D. Dual infective pathology in patients
with cryptococcal meningitis. Neurology 1998;51:1213—5.].
Case report: An exceptionally rare case of concurrent central nervous system infection with
Cryptococcus neoformans and Mycobacterium tuberculosis in a 25-year-old otherwise healthy
Chinese student, who had very recently joined an Italian post-doctoral course, is described. Also
described are the diagnostic and therapeutic difficulties encountered in a five-month hospita-
lization period, when only transient and/or negligible immune system impairments were
detected.
Conclusions: This episode of very infrequent concurrent infections should emphasize the need to
maintain an elevated clinical suspicion for opportunistic infections and tuberculosis, even in the
absence of an obvious immunodeficiency and related epidemiological clues.
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While the incidence of pulmonary and extrapulmonary tuber-
culosis is growing in patients of advanced age, immunocom-
promised subjects, and immigrants coming in from
developing countries (in whom brain complications are also
seen with a frequency greater than that of the general
population),1,2 the concomitant occurrence of cerebral cryp-
tococcosis plus brain and respiratory tuberculosis in a young
and otherwise healthy patient, without an evident cause of
immunodeficiency and without an obvious exposure, is
exceedingly rare — unique, according to all the available
literature resources.3 In fact, to the best of our knowledge,
associated central nervous system (CNS) cryptococcosis and
tuberculosis has not ever been reported in the absence of a
full-blown immunodeficiency (such as that arising from an
uncontrolled HIV disease).
Case report
A 25-year-old post-doctoral female student from China, with
an unremarkable medical history and with no significant
epidemiological clues, who had been well up until a few
days after her arrival in Bologna to follow a Masters course at
the local University, was hospitalized due to the sudden
appearance and rapid worsening of hyperpyrexia, cough,
headache, vomiting, and neck and lumbar stiffness.
A lumbar puncture was performed, and examination of the
cerebrospinal fluid (CSF) showed an opalescent fluid, with
mild pleocytosis (leukocytes 125  106/l, large predomi-
nance of mononuclear cells), an increased albumin level
(1.72 g/l), and a very low glucose level (0.17 g/l). Both
microscopy and culture examination, plus a search for the
yeast-specific polysaccharide antigen, tested positive for
Cryptococcus neoformans only. However, when looking for
an expected, concurrent immunodeficiency, serology for HIV
and human T-lymphotropic virus (HTLV) were found to be
negative, and an expanded immunological—autoimmune—
rheumatological workup failed to reveal an evident under-
lying immunodeficiency or immune-related disorder. Only a
proportional reduction of CD4+ T-lymphocyte count was
found (29%, leading to an absolute value of 299  106
cells/l), together with a slight alteration in selected chemo-
tactic, phagocytic, and killing assays of polymorphonuclear
leukocytes, in the absence of other recognizable causes of
immune system impairment or disorder.
Exposure to pigeon droppings or other respiratory infec-
tious diseases (including tuberculosis) were ruled out. Our
patient immediately underwent treatment with high-dose IV
fluconazole (800 mg/day), followed after two weeks with IV
liposomal amphotericinB (at 3 mg/kg/day), since thenegative
results attained for all mycological assays (achieved after
three weeks) did not result in any significant arrest in the
clinical and especially the neurological deterioration (includ-
ing weight loss, persistent-irregular fever, asthenia,moderate
headache, dizziness, and the appearance of focal deficits of
oculomotor nerves, leading to diplopia and strabismus).
After five completed weeks of systemic antifungal treat-
ment, CSF pleocytosis and increased albumin and decreased
glucose levels were still present, together with the findings of
intrathecal immunoglobulin synthesis and persistently nega-
tive cryptococcal searches. It was only at this time that wewere able to observe the first slow growth of Mycobacterium
tuberculosis from the original cultured CSF, in the absence of
other positive microscopic and culture searches on repeated
sputum, bronchoalveolar lavage fluid, and urine searches, and
in the absence of a positive Mantoux intradermal reaction.
In a computed tomography (CT) scan of the thorax on
admission, some small nodular lesions (1—12 mm diameter)
were in evidence in the right basal segments, but five weeks
later (at the point when a diagnosis of tubercular meningitis
was finally achieved and an isolate antifungal therapy deliv-
ered), an increased number of infiltrates with greater size
was demonstrated, with a tendency to initial cavitation of
the largest ones. A series of contrast-enhanced CT examina-
tions of the brain, initially negative for lesions, showed
numerous leptomeningeal lesions during the subsequent
weeks involving temporal, frontal, pontocerebellar, and
hypothalamic sites, interpreted as infectious-inflammatory
localizations; these were better evident with the aid of
magnetic resonance imaging (MRI), when the involvement
of base and fourth ventricle cisterns and associated cranial
nerves also became apparent (Figure 1).
Repeated CSF examinations pointed to a persistently
increased leukocyte count (represented by 80—90% mono-
nuclear cells), increased albumin content, and low glucose
levels, with microscopic, culture, and PCR investigations
remaining positive for M. tuberculosis for the first two
months. At the first signs of a positive M. tuberculosis CSF
culture, anti-tubercular treatment including five drugs (iso-
niazid, rifampin, ethambutol, pyrazinamide, and streptomy-
cin) was immediately started and continued for months.
After the first two months, due to a persistently positive
CSF examination and deteriorating clinical—neurological
conditions, the anti-tubercular regimen was further poten-
tiated with the addition of fluoroquinolones (for three
months) and linezolid (for two months).
In spite of the very slowclinical—neurological response, the
body weight loss, and the concurrent development of treat-
ment adverse events (gastrointestinal disturbances, altered
serum liver and pancreatic enzymes, and overwhelming sen-
sory-motor polyneuropathies), after more than five consecu-
tive months of hospitalization, thanks also to an extensive
rehabilitation program and the undertaking of anti-tubercular
chemotherapy, a very slow improvement in her clinical, neu-
rological, and neuro-radiological picture was finally achieved,
with almost complete recovery of posture, mobility, and deep
tendon reflexes, whichwere severely compromised during the
most acute phase of CNS tubercular infection.
Starting at the third month of hospitalization, all the
numerous, repeated microbiological controls tested negative
for both cryptococcosis and tuberculosis, when examining
CSF, respiratory secretions, and urine, while the absolute
CD4+ lymphocyte count rose to 399  106 cells/l at the last
control (fifth month).
Discussion
The present case report, which describes the exceptional
occurrence of two severe CNS infections — cryptococcosis
and tuberculosis together with a non-bacillary pulmonary
tuberculosis — in an otherwise healthy young girl who had
recently come to Italy from China, with an unremarkable
medical history, no evident exposure, and without obvious
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Figure 1 Magnetic resonance imaging (MRI) of the brain of our
patient who developed multiple CNS localizations of a neurolo-
gical and pulmonary tubercular infection, concurrent with a
meningeal cryptococcosis. Numerous leptomeningeal lesions in
temporal, frontal, pontocerebellar, and hypothalamic sites are
interpreted as infectious-inflammatory localizations on gadoli-
nium-enhanced MRI, which also shows the involvement of base
and fourth ventricle cisterns, periventricular sites, and asso-
ciated cranial nerve nuclei.causes of immunodeficiency, is a strong invitation to take into
careful consideration the most infrequent etiologies when a
meningeal inflammation is detected and a first diagnosis of
rare opportunism has already been made.
Episodes of CNS cryptococcosis like the one described
herein, remain extremely rare events when a concurrent
HIV disease is excluded;4,5 the international literature
reports only two anecdotal cases of concomitant CNS cryp-
tococcosis and tuberculosis or tuberculoma in a South African
patient with AIDS, followed in the pre-HAART era.3 HIV
infection and related diseases were repeatedly searched
for and excluded in our patient, whose proportionally
reduced absolute CD4+ lymphocyte count and a slight impair-
ment of some leukocyte functions could be attributed to the
underlying, invasive CNS and pulmonary tuberculosis, as
repeatedly observed.6 From a pathogenetic point of view,
sparse episodes of the so-called ‘idiopathic CD4+ deficiency’
have been anecdotally described7,8 in patients suffering from
opportunistic infections,7 but also in asymptomatic indivi-duals and in subjects with different, concurrent non-infec-
tious disorders.8
When considering the first disease diagnosed — CNS cryp-
tococcosis — a cryptococcal antigen test is very affordable
and a highly sensitive and specific technique,4,9 especially
when microscopic and culture assays of the CSF complete the
identification. On the other hand, disseminated tuberculosis,
especially in CNS localizations, remains notoriously difficult
to diagnose,10 although familiarity with its clinical manifes-
tations is reemerging following the recent, novel increase in
tuberculosis incidence in the industrialized world.1,2
From a therapeutic point of view, the apparently limited
clinical (but not microbiological) response to the first high-
dose fluconazole cycle prompted an early shift to liposomal
amphotericin B;4 following this, the lack of remission of the
majority of the clinical—neurological signs and symptoms,
and the parallel worsening of respiratory signs, are easily
attributed to the concurrent tubercular infection, which was
not immediately recognized by microscopic search and Man-
toux intradermal reaction. This tubercular infection was only
detected after the standard culture time (five weeks) and
was repeatedly confirmed thereafter, while the cryptococcal
disease was completely cured after three weeks of antifungal
therapy.
According to recent evidence, last-generation fluoroqui-
nolones11 and linezolid (due to its elevated tissue penetra-
tion and its favorable in vitro activity against
mycobacteria),12 may make valuable contributions to the
multi-drug treatment of CNS tuberculosis, although their
extensive administration along with multiple other anti-
tubercular drugs did not allow us to determine the specific
role played by either fluoroquinolone or linezolid co-admin-
istration in our particular case report.
To conclude, in patients who develop an unexpected
opportunistic infection even in the absence of evident causes
of immunodeficiency, underlying disorders, and obvious risk
factors, the clinical suspicion for further, underlying disor-
ders should not be disregarded, since additional, unsus-
pected disorders could remain undetected resulting in
delayed diagnosis and treatment.
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